Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-02-22

Clinical Trial Update: Effect of Alfacalcidol on Muscle Function in Osteoporosis Patients [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating alfacalcidol effects on muscle function in osteoporosis-related sarcopenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alfacalcidol (alfacalcidol)

Snippet

Sponsor: Yonsei University | Conditions: Sarcopenia | Phase 4 | Status: UNKNOWN